XML 60 R6.htm IDEA: XBRL DOCUMENT v3.19.3
Condensed Consolidated Statement of Shareholders' Equity (Unaudited) - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-In Capital
Deferred Compensation Equity
Accumulated Other Comprehensive Income (loss)
Retained Earnings
Shares in Treasury
Increase (Decrease) in Shareholders' Equity              
Adoption of accounting standards | Adjustments for New Accounting Pronouncement $ 6.5       $ (6.5) $ 13.0  
Balance at the beginning of the period at Dec. 31, 2017 2,528.3 $ 78.7 $ 353.7 $ 10.4 (85.7) 2,820.8 $ (649.6)
Balance (in shares) at Dec. 31, 2017   61,800,000         16,600,000
Increase (Decrease) in Shareholders' Equity              
Net income 523.0         523.0  
Other comprehensive income (loss), net of tax (18.5)       (18.5)    
Cash dividends (69.7)         (69.7)  
Repurchases of common stock (299.9)           $ (299.9)
Repurchases of common stock (in shares)   (2,700,000)         2,700,000
Issuances and deferrals. net for stock based compensation (1) [1] 36.0   24.1 (2.1)     $ 14.0
Issuances and deferrals, net for stock based compensation (in shares) [1]   500,000         (500,000)
Balance at the end of the period at Sep. 30, 2018 2,705.7 $ 78.7 377.8 8.3 (110.7) 3,287.1 $ (935.5)
Balance (in shares) at Sep. 30, 2018   59,600,000         18,800,000
Balance at the beginning of the period at Jun. 30, 2018 2,672.3 $ 78.7 365.8 7.8 (102.9) 3,211.5 $ (888.6)
Balance (in shares) at Jun. 30, 2018   59,800,000         18,600,000
Increase (Decrease) in Shareholders' Equity              
Net income 99.7         99.7  
Other comprehensive income (loss), net of tax (7.8)       (7.8)    
Cash dividends (24.1)         (24.1)  
Repurchases of common stock (59.3)           $ (59.3)
Repurchases of common stock (in shares)   (500,000)         500,000
Issuances and deferrals. net for stock based compensation (1) 24.9   12.0 0.5     $ 12.4
Issuances and deferrals, net for stock based compensation (in shares)   300,000         (300,000)
Balance at the end of the period at Sep. 30, 2018 2,705.7 $ 78.7 377.8 8.3 (110.7) 3,287.1 $ (935.5)
Balance (in shares) at Sep. 30, 2018   59,600,000         18,800,000
Balance at the beginning of the period at Dec. 31, 2018 $ 2,597.4 $ 78.7 383.8 $ 8.0 (122.1) 3,351.4 $ (1,102.4)
Balance (in shares) at Dec. 31, 2018 57,957,912 57,900,000         20,500,000
Increase (Decrease) in Shareholders' Equity              
Net income $ 370.2         370.2  
Other comprehensive income (loss), net of tax (22.5)       (22.5)    
Cash dividends (74.5)         (74.5)  
Repurchases of common stock (224.9)           $ (224.9)
Repurchases of common stock (in shares)   (1,900,000)         1,900,000
Issuances and deferrals. net for stock based compensation (1) [1] 35.3   21.2       $ 19.2
Issuances and deferrals, net for stock based compensation (in shares) [1]   500,000   (5,100,000)     (500,000)
Balance at the end of the period at Sep. 30, 2019 $ 2,681.0 $ 78.7 405.0 $ 2.9 (144.6) 3,647.1 $ (1,308.1)
Balance (in shares) at Sep. 30, 2019 56,674,890 56,500,000         21,900,000
Balance at the beginning of the period at Jun. 30, 2019 $ 2,583.2 $ 78.7 397.3 3.0 (120.5) 3,537.5 $ (1,312.8)
Balance (in shares) at Jun. 30, 2019   56,400,000         22,000,000.0
Increase (Decrease) in Shareholders' Equity              
Net income 137.9         137.9  
Other comprehensive income (loss), net of tax (24.1)       (24.1)    
Cash dividends (28.3)         (28.3)  
Repurchases of common stock 0.0           $ 0.0
Repurchases of common stock (in shares)   0         0
Issuances and deferrals. net for stock based compensation (1) 12.3   7.7 (0.1)     $ 4.7
Issuances and deferrals, net for stock based compensation (in shares)   100,000         (100,000)
Balance at the end of the period at Sep. 30, 2019 $ 2,681.0 $ 78.7 $ 405.0 $ 2.9 $ (144.6) $ 3,647.1 $ (1,308.1)
Balance (in shares) at Sep. 30, 2019 56,674,890 56,500,000         21,900,000
[1] Issuances and deferrals, net for stock based compensation reflects share activity related to option exercises, restricted and performance shares vested and net issuances and deferrals associated with deferred compensation equity.